Back to NRIX

Elmind Capital, LP → NRIX

Elmind Capital, LP NRIX Position History

Nurix Therapeutics, Inc.

Quarters held
4
Latest value
$10.9M
Q3 2026
Peak value
$11.2M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$8.7M
Q1 2026$7.1M
Q2 2026$11.2M
Q3 2026$10.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$10.9M460.0K——
Q2 2026$11.2M460.0K——
Q1 2026$7.1M460.0K——
Q4 2025$8.7M460.0K——

Other funds holding NRIX

Other Elmind Capital, LP positions

COGT

COGENT BIOSCIENCES INC

$45.3M
COGT

COGENT BIOSCIENCES INC

$45.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$43.3M
COGT

COGENT BIOSCIENCES INC

$41.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$40.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$39M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36.8M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36M